Information Provided By: 
Fly News Breaks for April 13, 2018
RAD
Apr 13, 2018 | 08:48 EDT
Cowen analyst Charles Rhyee noted Rite Aid reported better than expected EBITDA due to better than expected results in Pharmacy. The analyst said its guidance should provide investors with greater confidence of the company meeting its pro-forma targets, which validates his view that the shares appear undervalued. Rhyee reiterated his Outperform rating and $2.50 price target on Rite Aid shares.
News For RAD From the Last 2 Days
There are no results for your query RAD
